TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15148 · Sep 17

#cplusplus Monad is a fast, scalable Layer 1 blockchain fully compatible with Ethereum's EVM, allowing you to run Ethereum smart contracts without changes. It improves speed by separating consensus (agreement on transaction order) from execution (processing transactions), enabling parallel transaction execution and reaching 10,000 transactions per second with 1-second finality. Monad uses a custom EVM and a special database (MonadDb) optimized for parallel state access, reducing delays. This means you get much faster, cheaper transactions while keeping Ethereum compatibility, making it easier for developers and users to adopt and benefit from high performance and scalability. https://github.com/category-labs/monad

Hashtags

Results

1 similar post found

Search: #floodbase

当前筛选 #floodbase清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #4251 · 02/26/2025, 01:00 PM

Recent Funding Rounds Overview 🔍Funding Highlights: - Edera: $15M on Feb 25, 2025. Secure products launch. Learn more - Zhongjiang Keyi: $13.83M on Feb 24, 2025. Nanjing's new material tech firm. Learn more - Cholesgen: $13.83M on Feb 24, 2025. Innovating biopharmaceuticals for chronic diseases. Learn more - Magdrive: $10.50M on Feb 25, 2025. High-power propulsion system for space. Learn more - Arsenale Bioyards: $10M on Feb 25, 2025. Economical biomanufacturing through precision fermentation. Learn more - Paradox Immunotherapeutics: $10M on Feb 25, 2025. Focused on rare disease treatments. Learn more - BitDCA: $7.99M on Feb 24, 2025. New cryptocurrency distribution method. Learn more - Dametis: $7.33M on Feb 21, 2025. Software for environmental performance challenges. Learn more - QT Sense: $6.29M on Feb 25, 2025. Quantum sensing tech for biomedical research. Learn more - Floodbase: $5M on Feb 20, 2025. AI platform for flood risk insurance. Learn more #Funding#Edera#ZhongjiangKeyi#Cholesgen#Magdrive#ArsenaleBioyards#ParadoxImmunotherapeutics#BitDCA#Dametis#QTSense#Floodbase#Biotech#AI#Crypto#SpaceTech#Pharma#Innovation#EnvironmentalTech#QuantumTech#Biomanufacturing#RiskManagement